Prof. Schmuck has studied chemistry and obtained his PhD both at the Ruhruniversity in Bochum, working on stabilization energies of gas phase hydrocarbon radicals. After a postdocotoral stay with Prof. Ronmald Breslow at Columbia University in New York City (USA), where he worked on cyclodextrin-based enzyme mimetics, he started his own academic career at the University of Cologne (Germany). After his habilitation he beacem associate professor of organic chemistry at the University of Wuerzburg, before moving to his current position at the University of Duisburg-Essen, where he is now full professor and chair of organic chemistry as well as dean of the faculty of chemistry.
Dr. Ghosh worked as Scientist at Biocon and subsequently, he moved to IIT Kanpur for his doctoral studies in the area of peptide self-assembly. He joined as postdoctoral fellow at European Molecular Biology Laboratory, Heidelberg, Germany, where he worked on cell biology. He joined IICB Kolkata as Principal Scientist (E-II). He is a recipient of BIOCON Tribute award, Alexander von Humboldt Fellowship and Ramanujan Fellowship. Currently, he worked as Associate Editor of RSC Advances and became Fellow of the Royal Society of Chemistry (FRSC). His group is working in the area of chemical neuroscience and development of microtubule targeted anticancer therapeutics.
Vishal Rai received his Ph.D. in 2008 from IIT Bombay. After three years at the University of Toronto, he joined Department of Chemistry, IISER Bhopal in 2011 as Assistant Professor. His research interests are in the area of chemical technologies for protein modification. In 2016, he initiated a start-up company aimed at protein-labeling technologies propelled by the chemoselective and site-selective methods developed by his research group. He is the recipient of Ramanujan fellowship and DAE Young Scientist Award.
Dibyendu Das's Lab is working on the field of peptide based functional nanomaterials and catalytic amyloids for chemical evolution. Dibyendu did his PhD from IACS, India and postdoc from Emory University, USA. In 2013, he started his independent lab at INST Mohali and then shifted to IISER Tirupati in 2015.
Dr. R. Mahalakshmi is an Associate Professor in the Department of Biological Sciences at the Indian Institute of Science Education and Research in Bhopal. She did her Ph. D. from the Indian Institute of Science (2006) in peptide chemistry. She underwent postdoctoral training at the Burnham Institute for Medical Research (2008) and La Jolla Institute for Allergy and Immunology (2009). She is currently a recipient of the INSA Young Scientist award, NASI Young Scientist award, Associate of the Indian Academy of Sciences, and is a Wellcome Trust/ DBT India Alliance Intermedate Fellow.
Rituparna Sinha Roy has earned her PhD degree in the area of "Conformational analysis of designed alpha omega- hydrid peptides" from Molecular Biophysics Unit, IISc Bangalore. She did her postdoctoral studies at the Scripps Research Institute, San Diego in the area of biophysical studies of membrane protein and Harvard Medical School in the area of protein based therapeutics and nanobiotechnology. At present, she is Assistant Professor in the department of Biological Sciences at Indian Institute of Science Education and Research Kolkata. At IISER Kolkata, She is working in the area of peptide based therapeutics and nanobiotechnology.
Dr. Raja joined for Ph.D under the guidance of Prof. P. Balaram at Molecular Biophysics Unit, IISc, Bangalore for the doctoral research work on “conformational analysis of designed peptides”. He did his post-doctoral work with Prof. Jaume Torres at Nanyang Technological University, Singapore, where he investigated the structural aspects of Bt toxin and SARS CoV TMH peptides in membrane environments. Later he moved to work with Prof. Harald Schwalbe at BMRZ, Goethe-University, Frankfurt am Main, Germany, to develop potential peptide based inhibitors for HIV-1, targeting -RNA-NCp7 complex. Currently he is an Assistant Professor at MKU, focusing on the mechanistic elucidation on the folding and aggregations of homopeptide repeats, besides developing new building blocks in designing novel peptide/peptidomimic foldamers for versatile biomedical applications.
Dr Gajbhiye is a Physician-Scientist with more than 15 years of research experience in clinical,biomedical and public health. He is coordinating research activities at Andrology Clinic at NIRRH, NIRRH Field Units (31 centers in India) and recently initiated Model Rural Health Research Unit at Dahanu, Palghar, Maharashtra. His major research interests include endometriosis, male infertility,post partum haemorrhage, snake bite etc. He has several publications in national and international journals of high repute.
Dr. Apurba K. Das is an Associate Professor of Organic Chemistry at the Indian Institute of Technology Indore. His group's research interests are based on the development of new approaches to functional peptide based molecule synthesis and the influence of non-covalent interactions on structure and function from biology to chemistry to nanosciences. The group is focused on multidisciplinary research involving techniques in chemistry, biology and nanosciences. The group has a long-standing interest on supramolecular electronics, cell culture and nanocatalysis applications of synthesized self-assembled molecular materials.
Mariano Venanzi, Ph.D., is associate professor of Physical Chemistry at the University of Rome 'Tor Vergata' since 1998. He authorized more than 190 papers (120 dedicated to Peptide Science) on international peer reviewed journals (H-Index: 26 cit.: 2000). His scientific interests currently focus on the study of peptide aggregation and on the design of peptide hybrid materials.
As Professor of Chemistry and Biochemistry at the University of Delaware, Dr. Schneider was recruited in 2010 to the National Cancer Institute (NCI), National Institutes of Health to serve as Chief of the Chemical Biology Laboratory. He has developed an internationally recognized multidisciplinary Laboratory that emphasizes chemistry at the interface of biology and materials science, whose core mission is to discover and apply chemical methods, tools, and materials to define and manipulate biological processes that impact cancer and AIDS. In his independent research, Dr. Schneider is developing novel biomaterials for use in parenteral delivery of therapeutics, tissue regeneration, and antibacterial therapy. His work has produced over 90 publications, multiple patents and over 160 invited lectures.
Ankona received her B.Sc. and M.Sc. degrees in chemistry from the Indian Institute of Technology, Kharagpur in 2000. She did her graduate work on chiral water soluble porphyrins for catalysis and recognition with Prof. John T. Groves at Princeton University (Ph.D., 2006). After graduating from Princeton she joined as a postdoctoral scholar in the laboratory of Prof. Ken Raymond at the University of California, Berkeley, where she worked on macromolecular MRI contrast agents. Since 2010 she is a faculty in the Department of Chemical Science at the Tata Institute of Fundamental Research, India. Her current research interests are in the fields of Chemical Biology and Molecular Imaging.
Dr. Jimut Kanti Ghosh joined the CSIR-Central Drug Research institute, Lucknow, India as an independent scientist and a project investigator in the year 2001. Before joining this Institute, Dr. Ghosh did his doctoral studies from the Department of Biochemistry & Biophysics, Kalyani University and post-doctoral studies from the Molecular Biophysics Unit, IISc, Bangalore, Dept. of Biological; Chemistry, Weizmann Institute of Science, Israel and Department of Biology, University of California at San Diego, USA. One of the interests of his research group is to understand the structure-function relationships in membrane-associated proteins and peptides. His group has worked on pore-forming toxin, host defense peptides and ion-channel proteins. The primary objective of his research is to identify the important structural elements or amino acid sequences that contribute to the functional and biological activities of these selected protein/peptide and design of better bioactive peptides. At present his group is trying to develop new approaches for the design of novel, non-toxic, antimicrobial and anti-endotoxin peptides. The current interest of his Lab is also to identify/design novel osteogenic and anti-diabetic peptides. He is an elected fellow of National Academy of Sciences India (NASI).
The lab explores novel ways of identifying system wide interactions of biologically important proteins that are directly or indirectly involved in protein degradation. Using structural insights and bioinformatic tools, we identify conservation of Short Linear Sequence Motifs to discover putative interacting partners or ligands. Coupled with micro array, proteomic studies, available X-ray crystal structures, modeling and docking studies we validate our prediction using in vitro systems and cell based assays. The long term goal is to identify motif driven vulnerable networks in cancer that can be therapeutically intervened.
We use X-ray crystallography along with other biophysical/biochemical techniques to understand biological processes at molecular level. A major focus of the research in my lab is to investigate the role of protein-protein interactions that modulate transcription, electron transport and intercellular communications in bacteria. The group is also interested in investigating novel structural motifs in peptides and proteins.